875-P: Utilization of Continuous Glucose Monitors Is Associated with Reduction in Inpatient and Outpatient Emergency Acute Diabetes Events Regardless of Prior Blood Test Strip Usage

Author:

HIRSCH IRL B.1,KERR MATTHEW S.D.1,ROBERTS GREGORY J.1,SOUTO DIANA1,NABUTOVSKY YELENA1,BERGENSTAL RICHARD M.1

Affiliation:

1. Seattle, WA, Sylmar, CA, Alameda, CA, Santa Clara, CA, Minneapolis, MN

Abstract

Despite its potential benefits, access to continuous glucose monitors (CGMs) is often restricted based on blood glucose monitoring frequency. We aim to study if CGM efficacy depends on blood test strip (TS) usage prior to CGM initiation. IBM MarketScan™ Commercial Claims and Medicare Supplemental databases were used in this retrospective, observational analysis. MarketScan contains insurance billing claims for inpatient, outpatient and pharmacy expenses. Cohort requirements included: de novo CGM purchase in 2017 Q1-2018 Q2, type 1 or type 2 diabetes, ≥18 years old, fast- or short-acting insulin, ≥ 6-months pre-CGM observation time. Blood TS usage was determined based on purchases 6 months pre-CGM. Primary outcome was acute diabetes events (ADE): hospitalization with hyper-/hypoglycemia as the primary diagnosis or outpatient emergency associated with a code of hyper-/hypoglycemia. Andersen-Gill Cox regression compared event rates 6-months pre-/post-CGM. The cohort (n=12,521, age 43.8±15.2 years, 50.8% male, 77% type 1) experienced a reduction in ADE from 0.245 to 0.132 events/patient-year (HR: 0.54 [0.49 0.59]; P:<0.001). A similar reduction was seen in patients using <4 and ≥4 TS per day. A reduction was seen in all TS usage groups. Initiation of CGM use was associated with reduced ADE regardless of baseline blood TS usage. Disclosure I.B. Hirsch: Consultant; Self; Abbott, Bigfoot Biomedical, Roche Diabetes Care. Research Support; Self; Medtronic, Omnipod. M.S.D. Kerr: Employee; Self; Abbott. G.J. Roberts: Employee; Self; Abbott. D. Souto: Employee; Self; Abbott. Y. Nabutovsky: Employee; Self; Abbott. R.M. Bergenstal: Consultant; Self; Ascensia Diabetes Care, Johnson & Johnson. Other Relationship; Self; Abbott, Dexcom, Inc., Hygieia, Lilly Diabetes, Medtronic, Novo Nordisk A/S, Onduo, Roche Diabetes Care, Sanofi, UnitedHealth Group.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3